We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

0001062993-20-000281 Sample Contracts

TRILLIUM THERAPEUTICS INC. 35,731,818 Common Shares 1,250,000 Series II Non- Voting Convertible First Preferred Shares UNDERWRITING AGREEMENT
Underwriting Agreement • January 23rd, 2020 • Trillium Therapeutics Inc. • Pharmaceutical preparations • New York

Standard Contracts